Tag: Multiple Myeloma

Policy and Governance

A New Era for Multiple Myeloma Care

www.crystalskullworldday.com – Health care & hospitals are entering a pivotal moment with the U.S. approval of a DARZALEX FASPRO®-based quadruplet regimen for newly diagnosed multiple myeloma patients who cannot undergo stem cell transplant. This therapy, built on four coordinated medicines, has demonstrated deeper, longer-lasting responses than long‑standing standards of care, reshaping expectations for both clinicians […]

Back To Top